Miebo (Miebo) Rx Price Comparison: US vs Canada

Our most recent US pharmacy data shows a low of roughly $809.73 for Miebo with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

We found Canadian pricing for Miebo starting near $9.19 per tablet in USD terms. That's before any shipping charge, which the table above breaks out separately.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. Check the comparison table above for the specific numbers on Miebo.

Generic and brand-name pricing for Miebo is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

The amount you pay for Miebo with insurance depends entirely on your specific plan's formulary and coverage rules. Some plans may cover it with a standard copay, while others may not include it at all. Contact your insurer for details on your coverage and expected out-of-pocket cost. If your plan does not cover Miebo or your copay is high, you can use a pharmacy savings program to access a discounted cash price, which is often lower than the standard retail cost. Patients with Medicare or Medicaid can also use these savings programs if their plan does not provide coverage. Additionally, the manufacturer may offer a copay assistance card for eligible patients, which is another option to explore.

No, Miebo is currently only available as a brand-name medication manufactured by Bausch & Lomb. There is no FDA-approved generic equivalent. This means cost-saving options are generally limited to insurance coverage, manufacturer assistance, or pharmacy discount programs, which can lower the cash price.

Miebo is a prescription eye drop used to manage the signs and symptoms of dry eye disease in adults. Dry eye disease occurs when the eyes produce insufficient tears or tears evaporate too quickly, leading to discomfort, irritation, and a gritty sensation. The active ingredient is perfluorohexyloctane. While its precise mechanism is not fully understood, it is believed to work by forming a protective layer on the eye's surface to reduce tear evaporation. Miebo is manufactured by Bausch & Lomb and is not approved for use in individuals under 18 years of age.